192 related articles for article (PubMed ID: 3890658)
1. Cefamandole and cefoxitin.
Sanders CV; Greenberg RN; Marier RL
Ann Intern Med; 1985 Jul; 103(1):70-8. PubMed ID: 3890658
[TBL] [Abstract][Full Text] [Related]
2. Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of cefamandole and cefoxitin.
Fraser DG
Am J Hosp Pharm; 1979 Nov; 36(11):1503-8. PubMed ID: 391032
[No Abstract] [Full Text] [Related]
3. Cefamandole and cefoxitin.
Med Lett Drugs Ther; 1979 Feb; 21(3):13-5. PubMed ID: 310945
[No Abstract] [Full Text] [Related]
4. Newer cephalosporins and cephamycins--a review.
Norrby R
Scand J Infect Dis Suppl; 1978; (13):83-7. PubMed ID: 356183
[TBL] [Abstract][Full Text] [Related]
5. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
Goering RV; Sanders CC; Sanders W
J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
[TBL] [Abstract][Full Text] [Related]
6. The in vitro spectrum of the cephalosporins.
Washington JA
Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
[TBL] [Abstract][Full Text] [Related]
7. Serum and tissue concentrations of cefoxitin and cefamandole in women undergoing hysterectomy.
French MA; Quintiliani R; Nightingale CH; Russo JN
Obstet Gynecol; 1983 Jan; 61(1):42-7. PubMed ID: 6823348
[TBL] [Abstract][Full Text] [Related]
8. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
Eickhoff TC; Ehret JM
Antimicrob Agents Chemother; 1976 Jun; 9(6):994-9. PubMed ID: 938029
[TBL] [Abstract][Full Text] [Related]
9. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.
Tartaglione TA; Polk RE
Drug Intell Clin Pharm; 1985 Mar; 19(3):188-98. PubMed ID: 3884304
[TBL] [Abstract][Full Text] [Related]
10. Correlation of in vitro susceptibility with in vivo efficacy in mice for cefoxitin in comparison with cephalosporins.
Miller AK; Celozzi E; Pelak BA; Birnbaum J; Stapley EO
J Antimicrob Chemother; 1979 Sep; 5(5):569-79. PubMed ID: 315403
[TBL] [Abstract][Full Text] [Related]
11. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae.
Phillips I; Shannon K
Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833
[TBL] [Abstract][Full Text] [Related]
12. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1979 Jan; 17(1):1-37. PubMed ID: 369806
[TBL] [Abstract][Full Text] [Related]
13. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
Barry AL; Jones RN; Thornsberry C
Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
[TBL] [Abstract][Full Text] [Related]
14. Update on drug therapy. IV. Parenteral cephalosporins.
Dahl SL; Elenbaas J; Hamburger S
J Am Med Womens Assoc (1972); 1980 Apr; 35(4):99-100, 107-8. PubMed ID: 6246160
[No Abstract] [Full Text] [Related]
15. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
Brorson JE; Norrby R
Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150
[No Abstract] [Full Text] [Related]
16. Review of cefonicid, a long-acting cephalosporin.
Dudley MN; Quintiliani R; Nightingale CH
Clin Pharm; 1984; 3(1):23-32. PubMed ID: 6365414
[TBL] [Abstract][Full Text] [Related]
17. Cefonicid: a long-acting, second-generation cephalosporin. Antimicrobial activity, pharmacokinetics, clinical efficacy and adverse effects.
Pontzer RE; Kaye D
Pharmacotherapy; 1984; 4(6):325-33. PubMed ID: 6393074
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vivo efficiency of cefamandole and cefoxitin against Bacteroides fragilis.
Bergeron MG; Gauvreau L; Nguyen BM
Scand J Infect Dis Suppl; 1980; suppl 25():60-5. PubMed ID: 6937954
[TBL] [Abstract][Full Text] [Related]
19. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
Harper PB
Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of cefonicid sodium versus cefoxitin sodium for the prevention of postoperative infections after nonelective cesarean section.
Briggs GG; Moore BR; Bahado-Singh R; Lange S; Bogh P; Garite TJ
Clin Pharm; 1987 Sep; 6(9):718-21. PubMed ID: 3119278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
